Neuroradiological manifestations of primary Sjögren's syndrome;Manifestations neurologiques du syndrome de Sjögren primitif

Revue Neurologique

Volumn 158, Issue 10 I, 2002, Pages 959-965

  Lafitte, C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

BRAIN DYSFUNCTION; COGNITIVE DEFECT; CONNECTIVE TISSUE DISEASE; CORTICOSTEROID THERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MENTAL DISEASE; MOTOR NEURON DISEASE; MYELITIS; PERIPHERAL NEUROPATHY; REVIEW; SENSORIMOTOR NEUROPATHY; SENSORY NEUROPATHY; SJOEGREN SYNDROME; SPINAL CORD DISEASE;

CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM DISEASES; SJOGREN'S SYNDROME;

EID: 0036807013     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Alexander EL, Alexander GE. (1983). Aseptic meningoencephalitis in primary Sjögren's syndrome. Neurology, 33: 593-598.
2. Alexander EL. (1993). Neurologic disease in Sjögren's syndrome: Mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am, 19:869-908.
3. Alexander EL, Ranzenbach MR, Kumar AJ et al. (1994). Anti-Ro (SS-A) autoantibodies in central nervous system disease associated with Sjögren's syndrome: Clinical, neuroimaging, and angiographic correlates. Neurology, 14: 899-908.
4. Anaya JM, Talal N. (1999). Sjögren's syndrome comes of age. Semin Arthritis Rheum, 28: 355-359.
5. Andonopoulos AP, Lagos G, Drosos AA, Moutsopoulos HM. (1990). The spectrum of neurological involvement in Sjögren's syndrome. Br J Rheumatol, 29: 21-23.
6. Andonopoulos AP, Christodoulou J, Ballas C, Bounas A, Alexopoulos D. (1998). Autonomic cardiovascular neuropathy in Sjögren's syndrome. A controlled study. J Rheumatol, 25: 2385-2388.
7. Bakchine S, Duyckaerts C, Hassine L, Chaunu MP, Turell E, Wechsler B, Chain F. (1991). Lésions neurologiques centrales et périphériques au cours d'un syndrome de Gougerot-Sjögren primitif. Rev Neurol, 147: 368-375.
8. Barnes D, Hammans SR, Legg NJ. (1988). Chronic relapsing inflammatory polyneuropathy complicating sicca syndrome. J Neurol Neurosurg Psychiatry, 51: 159-160.
9. Belin C, Moroni C, Caillat-Vigneron N, et al. (1999). Central nervous system involvement in Sjögren's syndrome: Evidence from neuropsychological testing and HMPAO-SPECT. Ann Med Interne, 150: 598-604.
10. Binder A, Snaith ML, Isenberg D. (1988). Sjögren's syndrome: A study of its neurological complications. Br J Rheumatol, 27: 275-280.
11. Boscagli A, Hatron PY, Canva-Delcambre V, Hachulla E, Janin A, Paris C, Devulder B. (1996). Syndrome sec et infection par le virus C de l'hépatite: Un pseudo-syndrome Gougerot-Sjögren? Rev Med Interne, 17: 375-380.
12. Caselli RJ, Scheitauer BW, Bowles CA, Trenerry MR, Meyer FB, Smigielski JS. (1991). The treatable dementia of Sjögren's syndrome. Ann Neurol, 30: 98-101.
13. Caselli RJ, Scheitauer BW, O'Duffy JD, Peterson GC, West-Moreland BF, Davenport PA. (1993). Chronic inflammatory meningoencephalitis should not be mistaken for Alzheimer disease. Mayo Clin Proc, 68: 846-853.
14. Coates T, Slavotinek JP, Rischmueller M, et al. (1999). Cerebral white matter lesions in primary Sjögren's syndrome: A controlled study. J Rheumatol, 26: 1301-1305.
15. Coll J, Gambus G, Corominas J, Tomas S, Esteban JI, Guardia J. (1997). Immunohistochemistry of minor salivary gland biopsy specimens from patients with Sjögren's syndrome with and without hepatitis C virus infection. Ann Rheum Dis, 56: 390-392.
16. Créange A, Laplane D, Habib K, Attal N, Assuėrus V. (1992). Démence révélatrice d'un syndrome de Gougerot-Sjögren primitif. Rev Neurol, 148: 376-380.
17. Dalmau J, Graus F, Rosenblum MK, Posner JB. (1992). Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine, 71: 59-72.
18. Daniels TE, Whitcher JP. (1994). Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum, 37: 869-877.
19. De Seze J, Stojkovic T, Hachulla E, et al. (2001). Myélopathies et Sjögren's syndrome: Étude clinique, radiologique et profil évolutif. Rev Neurol, 157: 669-678.
20. Fabre N, Faucheux JM, Roland Y, Cantagrel A, Geraud G. (1996). Corticosteroid-responsive parkinsonism associated with primary Sjögren's syndrome: Report of two cases. Neurology, 46 (Suppl 1): A299-A300.
21. Gemignani F, Marbini A, Pavesi G, Di Vittorio S, Manganelli P, Cenacchi G, Mancia D. (1994). Peripheral neuropathy associated with primary Sjögren's syndrome. J Neurol Neurosurg Psychiatry, 57: 983-986.
22. Gerraty RP, McKelvie PA, Byrne E. (1993). Aseptic meningoencephalitis in primary Sjögren's syndrome. Response to plasmapheresis and absence of CNS vasculitis at autopsy. Acta Neurol Scand, 88: 309-311.
23. Govoni M, Bajocchi G, Rizzo N, et al. (1999). Neurological involvement in primary Sjögren's syndrome: Clinical and instrumental evaluation in a cohort of Italian patients. Clin Rheumatol, 18: 299-303.
24. Grant IA, Hunder GG, Homburger HA, Dyck PJ. (1997). Peripheral neuropathy associated with sicca complex. Neurology, 48: 855-862.
25. Griffin JW, Comblath DR, Alexander E, Campbell J, Low PA, Bird S, Feldman EL. (1990). Ataxie sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol, 27: 304-315.
26. Gross M. (1987). Chronic relapsing inflammatory polyneuropathy complicating sicca syndrome. J Neurol Neurosurg Psychiatry, 50: 939.
27. Hictaharju A, Yli-Kerttula U, Häkkinen V, Frey H. (1990). Nervous system manifestations in Sjögren's syndrome. Acta Neurol Scand, 81: 144-152.
28. Kaltreider HB, Talal N. (1969). The neuropathy of Sjögren's syndrome. Trigeminal nerve involvement. Ann Intern Med, 70: 751-762.
29. Kaplan G, Mariette X. (2000). Syndrome de Gougerot-Sjögren. In Kahn MF, Peltrier AP, Meyer O, Piette JC, Maladies et Syndromes Systémiques. 533-573. Médecine-Sciences Flammarion. Paris.
30. Kassan SS, Thomas TL, Moutsopoullos HM, Hoover R, Kimberly RP, Budman DR, Costa J, Decker JL, Chused TM. (1978). Increased risk of lymphoma in sicca syndrome. Ann Intern Med, 89: 888-892.
31. Katz JS, Houroupian D, Ross MA. (1999). Multisystem neuronal involvement and sicca complex: Broadening the spectrum of complications. Muscle Nerve, 22: 404-407.
32. Kawashima N, Shindo R, Kohno M. (1993). Primary Sjögren's syndrome with subcortical dementia. Intern Med, 32: 561-564.
33. Kraus A, Cifuentes M, Villa AR, Jakez J, Reyes E, Alarcon-Segovia D. (1994). Myositis in primary Sjögren's syndrome. Report of 3 cases. J Rheumatol, 21: 649-653.
34. Lafitte C. (1998). Manifestations neurologiques du syndrome de Gougerot-Sjögren primitif. Rev Neurol, 154: 658-673.
35. Lafitte C. (2000). Neurological manifestations in Sjögren's syndrome. Arch Neurol, 57: 411-413.
36. Lafitte C, Amoura Z, Cacoub P, et al. (2001). Neurological complications of primary Sjögren's syndrome. J Neurol, 248: 577-584.
37. Lyu RK, Chen ST, Tang LM, Chen TC. (1995). Acute transverse myelopathy and cutaneous vasculopathy in primary Sjögren's syndrome. Eur Neurol, 35: 359-362.
38. Malinow KL, Molina R, Gordon B, Selnes OA, Provost TT, Alexander EL. (1985). Neuropsychiatric dysfunction in primary Sjögren's syndrome. Ann Intern Med, 103: 344-349.
39. Mandl T, Bornmyr SV, Castenfors J, Jacobsson LTH, Manthorpe R, Wollmer P. (2001). Sympathetic dysfunction in patients with primary Sjögren's syndrome. J Rheumatol, 28: 296-301.
40. Manthorpe R, Asmussen K, Oxholm P. (1997). Primary Sjögren's syndrome: diagnostic criteria, clinical features, disease activity. J Rheumatol, 24 Suppl 50: 8-11.
41. Manthorpe R, Jacobsson LTH, Kirtava Z, Theander E. (1998). Epidemiology of Sjögren's syndrome, especially its primary form. Ann Med Interne, 149: 7-11.
42. Matsukawa Y, Nishinarita S, Horie T. (1995). Abducent and trochlear palsies in a patient with Sjögren's syndrome. Br J Rheumatol, 34: 484-485.
43. Mellgren SI, Conn DL, Stevens JC, Dyck PJ. (1989). Peripheral neuropathy in primary Sjögren's syndrome. Neurology, 39: 390-394.
44. Mori K, Koike H, Misu K, Hattori N, Ichimura M, Sobue G. (2001). Spinal cord magnetic resonance imaging demonstrates sensory neuronal involvement and clinical severity in neuronopathy associated with Sjögren's syndrome. J Neurol Neurosurg Psychiatry, 71: 488-492.
45. Owada K, Uchihara T, Ishida K, Mizusawa H, Watabiki S, Tsuchiya K. (2002). Motor weakness and cerebellar ataxia in Sjögren syndrome-identification of antineuronal antibody: A case report. J Neurol Sci, 197: 79-84.
46. Pou Serradell A, Vinas Gaya J. (1993). Trois cas de neuropathies périphériques rares associées au syndrome de Goujerot-Sjögren primitif. Rev Neurol, 149: 481-484.
47. Sobue G, Yasuda T, Kumazawa K, Yamamoto K, Mitsuma T. (1995). MRI demonstrates dorsal column involvement of the spinal cord in Sjögren's syndrome-associated neuropathy. Neurology, 45: 592-593.
48. Urban PP, Keilmann A, Teichmann EM, Hopf HC. (2001). Sensory neuropathy of the trigeminal, glossopharyngeal, and vagal nerves in Sjögren's syndrome. J Neurol Sci, 186: 59-63.
49. Valls-Sole J, Graus F, Font J, Pou A, Tolosa ES. (1990). Normal proprioceptive trigeminal afferents in patients with Sjögren's syndrome and sensory neuronopathy. Ann Neurol, 28: 786-790.
50. Valtysdottir ST, Gudbjornsson B, Lindqvist U, Hallgren R, Hetta J. (2000). Anxiety and depression in patients with primary Sjögren's syndrome. J Rheumatol, 27: 165-169.
51. Vincent D, Loron P, Awada A, Gautier JC. (1985). Paralysies multiples et récidivantes des nerfs crâniens. Syndrome de Gougerot-Sjögren. Rev Neurol, 141: 318-321.
52. Vitali C, Bombardieri S, Moutsopoulos HM, etal. (1996). Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective study. Ann Rheum Dis, 55: 116-121.
53. Vrethem M, Lindvall B, Holmgren H, Henriksson KG, Lindström F, Ernerudh J. (1990). Neuropathy and myopathy in primary Sjögren's syndrome: Neurophysiological, immunological and muscle biopsy results. Acta Neurol Scand, 82: 126-131.
54. West SG. (1994). Neuropsychiatric lupus. Rheum Dis Clin North Am, 20: 129-158.
55. Williams CS, Butler E, Roman GC. (2001). Treatment of myelopathy in Sjögren syndrome with a combination of prednisone and cyclophosphamide. Arch Neurol, 58: 815-819.